Plant cell factories in the post-genomic era: New ways to produce designer secondary metabolites

Kirsi-Marja Oksman-Caldentey (Corresponding Author), Dirk Inze

Research output: Contribution to journalArticleScientificpeer-review

320 Citations (Scopus)

Abstract

Plants synthesize an extensive array of secondary metabolites, often with highly complex structures. Currently, most pharmaceutically important secondary metabolites are isolated from wild or cultivated plants because their chemical synthesis is not economically feasible. Biotechnological production in plant cell cultures is an attractive alternative, but to date this has had only limited commercial success because of a lack of understanding of how these metabolites are synthesized. Here, we discuss how the spectacular advances in plant genomics and metabolite profiling offer unprecedented possibilities to explore the extraordinary complexity of the plant biochemical capacity. State-of-the art genomics tools can be used to enhance the production of known target metabolites or to synthesize entire novel compounds by so-called combinatorial biochemistry in cultivated plant cells.
Original languageEnglish
Pages (from-to)433 - 440
Number of pages8
JournalTrends in Plant Science
Volume9
Issue number9
DOIs
Publication statusPublished - 2004
MoE publication typeA1 Journal article-refereed

Fingerprint

factories
secondary metabolites
genomics
cells
metabolites
biochemistry
cell culture
synthesis

Keywords

  • metabolomics
  • plant metabolites
  • metabolites
  • secondary metabolism
  • secondary metabolites
  • plants

Cite this

@article{5c2724e18e0f43368fc9457d44011a33,
title = "Plant cell factories in the post-genomic era: New ways to produce designer secondary metabolites",
abstract = "Plants synthesize an extensive array of secondary metabolites, often with highly complex structures. Currently, most pharmaceutically important secondary metabolites are isolated from wild or cultivated plants because their chemical synthesis is not economically feasible. Biotechnological production in plant cell cultures is an attractive alternative, but to date this has had only limited commercial success because of a lack of understanding of how these metabolites are synthesized. Here, we discuss how the spectacular advances in plant genomics and metabolite profiling offer unprecedented possibilities to explore the extraordinary complexity of the plant biochemical capacity. State-of-the art genomics tools can be used to enhance the production of known target metabolites or to synthesize entire novel compounds by so-called combinatorial biochemistry in cultivated plant cells.",
keywords = "metabolomics, plant metabolites, metabolites, secondary metabolism, secondary metabolites, plants",
author = "Kirsi-Marja Oksman-Caldentey and Dirk Inze",
year = "2004",
doi = "10.1016/j.tplants.2004.07.006",
language = "English",
volume = "9",
pages = "433 -- 440",
journal = "Trends in Plant Science",
issn = "1360-1385",
publisher = "Elsevier",
number = "9",

}

Plant cell factories in the post-genomic era : New ways to produce designer secondary metabolites. / Oksman-Caldentey, Kirsi-Marja (Corresponding Author); Inze, Dirk.

In: Trends in Plant Science, Vol. 9, No. 9, 2004, p. 433 - 440.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Plant cell factories in the post-genomic era

T2 - New ways to produce designer secondary metabolites

AU - Oksman-Caldentey, Kirsi-Marja

AU - Inze, Dirk

PY - 2004

Y1 - 2004

N2 - Plants synthesize an extensive array of secondary metabolites, often with highly complex structures. Currently, most pharmaceutically important secondary metabolites are isolated from wild or cultivated plants because their chemical synthesis is not economically feasible. Biotechnological production in plant cell cultures is an attractive alternative, but to date this has had only limited commercial success because of a lack of understanding of how these metabolites are synthesized. Here, we discuss how the spectacular advances in plant genomics and metabolite profiling offer unprecedented possibilities to explore the extraordinary complexity of the plant biochemical capacity. State-of-the art genomics tools can be used to enhance the production of known target metabolites or to synthesize entire novel compounds by so-called combinatorial biochemistry in cultivated plant cells.

AB - Plants synthesize an extensive array of secondary metabolites, often with highly complex structures. Currently, most pharmaceutically important secondary metabolites are isolated from wild or cultivated plants because their chemical synthesis is not economically feasible. Biotechnological production in plant cell cultures is an attractive alternative, but to date this has had only limited commercial success because of a lack of understanding of how these metabolites are synthesized. Here, we discuss how the spectacular advances in plant genomics and metabolite profiling offer unprecedented possibilities to explore the extraordinary complexity of the plant biochemical capacity. State-of-the art genomics tools can be used to enhance the production of known target metabolites or to synthesize entire novel compounds by so-called combinatorial biochemistry in cultivated plant cells.

KW - metabolomics

KW - plant metabolites

KW - metabolites

KW - secondary metabolism

KW - secondary metabolites

KW - plants

U2 - 10.1016/j.tplants.2004.07.006

DO - 10.1016/j.tplants.2004.07.006

M3 - Article

VL - 9

SP - 433

EP - 440

JO - Trends in Plant Science

JF - Trends in Plant Science

SN - 1360-1385

IS - 9

ER -